nVerses Capital’s Bio-Techne TECH Stock Holding History

nVerses Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-800	Closed	-$57.3K	–	1379
2024 Q2	$57.3K	Buy	+800	New	+$58.9K	0.03%	569

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

nVerses Capital's TECH Position: Q3 2024 in Review

nVerses Capital sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 800 shares — an estimated $57.3K sold.

nVerses Capital first reported a position in TECH in Q2 2024 and held it in 1 quarter. The position peaked at $57.3K in Q2 2024. 561 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

nVerses Capital reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 800 Bio-Techne shares in Q3 2024, an estimated $57.3K.
nVerses Capital first reported a position in Bio-Techne in Q2 2024 and held it in 1 quarter.
nVerses Capital's Bio-Techne position peaked at $57.3K in Q2 2024.
561 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.